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Text S1: Calculating person years at risk for the incidence density analyses  
For incidence density analyses, we calculated person years at risk according to a previously 
described method[1] for each combination of categories of predictor variables included in 
regression analyses: calendar year, age (in years), sex, and distance category. Let  uxt  
represent the number of person years accrued by children aged u in year t with given sex and 
distance category. The values  ux1990  and  ux2000  were obtained from the census data for 
1990 and 2000 respectively. To calculate  ux1990 , we identified the children in 1990 census 
with the given combination of predictors and summed their individual person year 
contributions to age u during the 365 days preceding the census date. Person years  ux2000  
were calculated analogously. Person years  uxt  for non-census years were then calculated as 
a linear extra-/interpolation from the values  ux1990  and  ux2000 . To adjust for non-linear 
population fluctuations, we weighted the values  ux1990  and  ux2000  prior to extra-
/interpolation based on age and sex specific national population levels which were obtained 
from the Federal Office of Statistics for all years 1985-2008. Weights for  ux1990  and 
 ux2000  were equal to the ratio between the sex-specific population aged u in year t and the 
sex-specific population aged u in the years 1990 and 2000 respectively. In Poisson 
regression, cases belonging to the given combination of predictor values were then assigned 
the person years  uxt .
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Table S1: Characteristics of cancer cases included in analyses 
  
Included in time to 
event analysis 
N (%) 
Included in incidence 
density analysis 
N (%) 
    
All children  1783 (100.0) 4263 (100.0) 
    
ICCC3 main diagnostic 
group 
Leukaemias, myeloproliferative diseases, and myelodysplastic 
diseases 
532 (29.8) 1367 (32.1) 
 Lymphomas and reticuloendothelial neoplasms 326 (18.3) 574 (13.5) 
 CNS and miscellaneous intracranial and intraspinal neoplasms 420 (23.6) 890 (20.9) 
 Neuroblastoma and other peripheral nervous cell tumours 34 (1.9) 287 (6.7) 
 Retinoblastoma 21 (1.2) 111 (2.6) 
 Renal tumours 55 (3.1) 234 (5.5) 
 Hepatic tumours 14 (0.8) 44 (1.0) 
 Malignant bone tumours 128 (7.2) 209 (4.9) 
 Soft tissue and other extraosseous sarcomas 125 (7.0) 291 (6.8) 
 Germ cell tumours, trophoblastic tumours, and neoplasms of 
gonads 
48 (2.7) 117 (2.7) 
 Other malignant epithelial neoplasms and malignant melanomas 
or unspecified malignant neoplasms 
80 (4.5) 138 (3.2) 
Sex Male 994 (55.7) 2357 (55.3) 
 Female 789 (44.3) 1906 (44.7) 
Median age in years (IQR)  10.1 (6.1-13.2) 6.1 (2.7-11.7) 
 Abbreviations: ICCC3 International Classification of Childhood Cancers – 3rd Edition,[2] IQR interquartile range, CNS central nervous system 
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Table S2: Association between childhood cancer and highway traffic volume among 
children living <500 m from a highway (time to event analyses) 
 All vehicles Trucks only 
Outcome HRa (95% CI) 
per increase of 
10,000 veh/d  
P HRa (95% CI) 
per increase of 
1,000 veh/d  
P 
Leukaemia 1.02 (0.94, 1.11) 0.603 1.01 (0.92, 1.10) 0.906 
ALL 0.99 (0.90, 1.09) 0.806 1.00 (0.89, 1.11) 0.933 
Lymphoma 1.14 (1.04, 1.25) 0.005 1.10 (0.99, 1.21) 0.075 
CNS tumours 1.00 (0.90, 1.10) 0.950 1.01 (0.91, 1.12) 0.798 
Other malignant tumours 1.07 (0.98, 1.16) 0.118 1.08 (0.98, 1.18) 0.104 
All cancers 1.05 (1.01, 1.10) 0.021 1.05 (1.00, 1.10) 0.072 
 Abbreviations: ALL acute lymphoblastic leukaemia, CI confidence, CNS central nervous 
system, HR hazard ratio, veh/d vehicles per day 
a From Cox proportional hazard models adjusting for sex, birth year and distance to highway. 
 
  
5 
 
Table S3: Association between childhood cancer and highway traffic volume (incidence 
density analyses) 
 All vehicles Trucks only 
Outcome IRRa (95% CI) 
per increase of 
10,000 veh/d  
P IRRa (95% CI) 
per increase of 
1,000 veh/d  
P 
Analysis including children living <500 m from a highway 
Leukaemia 1.02 (0.96, 1.07) 0.522 1.02 (0.97, 1.09) 0.413 
ALL 1.01 (0.95, 1.07) 0.709 1.02 (0.96, 1.09) 0.528 
Lymphoma 1.06 (0.98, 1.14) 0.171 1.04 (0.95, 1.13) 0.427 
CNS tumours 1.01 (0.94, 1.08) 0.801 0.97 (0.90, 1.04) 0.362 
Other malignant tumours 1.04 (0.99, 1.09) 0.164 1.04 (0.98, 1.10) 0.162 
All cancers 1.03 (1.00, 1.06) 0.074 1.02 (0.99, 1.05) 0.258 
Analysis including children living <250 m from a highwayb 
Leukaemia 1.02 (0.94, 1.11) 0.591 1.04 (0.96, 1.14) 0.355 
ALL 1.02 (0.93, 1.11) 0.656 1.05 (0.95, 1.15) 0.331 
CNS tumours 0.94 (0.83, 1.07) 0.341 0.90 (0.77, 1.05) 0.167 
Other malignant tumours 1.02 (0.94, 1.11) 0.606 0.99 (0.90, 1.09) 0.892 
All cancers 1.01 (0.96, 1.06) 0.699 0.99 (0.94, 1.05) 0.851 
Analysis including children living <100 m from a highwayb 
Leukaemia 1.03 (0.91, 1.17) 0.638 1.03 (0.88, 1.20) 0.741 
ALL 1.04 (0.90, 1.19) 0.629 1.03 (0.87, 1.22) 0.756 
CNS tumours 0.92 (0.74, 1.14) 0.446 0.81 (0.60, 1.09) 0.171 
Other malignant tumours 1.07 (0.94, 1.23) 0.296 1.12 (0.96, 1.30) 0.143 
All cancers 1.03 (0.95, 1.12) 0.509 1.02 (0.93, 1.13) 0.630 
 Abbreviations: ALL acute lymphoblastic leukaemia, CI confidence, CNS central nervous 
system, IRR incidence rate ratio, veh/d vehicles per day 
a From Poisson regression models adjusting for sex, age, year of diagnosis, and distance to 
highway. 
b Lymphoma were not considered in these analyses due to the small number of cases. 
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Table S4: Association between childhood cancer and quartiles of highway traffic 
volume (incidence density analyses) 
Outcome Traffic density 
quartile 
IRRa (95% CI) P-valueb 
Any cancer 1st Q 1.00 0.44 
 2nd-3rd Q 0.99 (0.80,1.23)  
 4th Q 1.19 (0.94,1.50)  
Leukaemia 1st Q 1.00 1.00 
 2nd-3rd Q 1.04 (0.71,1.52)  
 4th Q 1.09 (0.71,1.66)  
ALL 1st Q 1.00 1.00 
 2nd-3rd Q 0.93 (0.62,1.41)  
 4th Q 0.99 (0.62,1.57)  
Lymphoma 1st Q 1.00 0.10 
 2nd-3rd Q 0.59 (0.33,1.06)  
 4th Q 1.22 (0.69,2.17)  
CNS tumours 1st Q 1.00 1.00 
 2nd-3rd Q 1.01 (0.65,1.58)  
 4th Q 1.03 (0.62,1.70)  
Other malignant tumours 1st Q 1.00 0.59 
 2nd-3rd Q 1.14 (0.78,1.66)  
 4th Q 1.39 (0.93,2.09)  
Q Quartile 
a From Poisson regression models adjusting for sex, age, year of diagnosis, and distance to 
highway  
b P-value from likelihood ratio test  
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Fig. S1: Eligibility of incident cases. Eligible cases (a, b, c) are those that contribute follow-
up time to the study if linked to the Swiss National Cohort (SNC). Non-eligible cases (d, e, f) 
cannot contribute follow-up time and were excluded from the SNC if linked (only d and e are 
linkable). 
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Fig. S2: Flow chart of study population. Both eligible and non-eligible cases (See Figure 1) 
were linked to the Swiss National Cohort. Non-eligible cases were subsequently excluded 
because they were diagnosed before entry into the cohort. 
 
 
  
10 
 
 
 
Fig. S3: Associations between leukaemia in children aged <5 years and distance of 
residence to nearest highway. Results from time-to-event analysis adjusting sex and birth 
year; time-to-event analysis adjusting for sex, birth year and other potential confounders; 
time-to-event analysis adjusting for sex and birth year in a subsample with stable place of 
residence 5 years preceding entry into cohort; incidence density analysis adjusting for sex, 
age and calendar year. Reference category is residence >500 m. 
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Fig S4: Interaction between time period of diagnosis and distance to nearest highway. 
Results from incidence density analyses including interaction terms between distance and 
time periods (1985-1999, 2000-2008) adjusting for sex, age at diagnosis and year of 
diagnosis. The reference category is residence >500 m in each calendar period respectively. 
P-values of likelihood ratio tests for interaction are shown. 
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Fig S5: Interaction between degree of urbanisation and distance to nearest highway. 
Results from incidence density analyses including interaction terms between distance and 
degree of urbanisation adjusting for sex, age at diagnosis and year of diagnosis. The reference 
category is residence >500 m in each stratum. P-values of likelihood ratio tests for interaction 
are shown. There were no observed cases of lymphoma for distance category <100 m in peri-
urban areas resulting in an estimate outside the range of the y-axis.   
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Fig S6: Smoothed relative risks for childhood cancer by distance from nearest highway. 
Results from incidence density analysis with distance as a continuous exposure variable 
adjusting for sex, age and calendar year and restricting to children living <1 km from a 
highway. Penalised cubic regression splines were used to model the association with distance 
and estimated risk. The estimated risk at 750 m was used as reference value (relative risk = 
1).  The shaded area represents point-wise 95% confidence intervals. 
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Fig S7: Interaction between quartiles (Q) of traffic volume and distance to nearest 
highway. Results from incidence density analyses including interaction terms between 
distance and traffic volume adjusting for sex, age at diagnosis and year of diagnosis. 
Reference category is 250-500 m from the nearest highway and 1st quartile of traffic volume. 
Analyses are restricted to children living <500 m from a highway. P-values of likelihood ratio 
tests for interaction are shown. There were no observed cases of lymphoma for the distance 
category <100 m and traffic volume quartiles 2-3 resulting in an estimate outside the range of 
the y-axis. 
